1. Home
  2. RYM vs FEMY Comparison

RYM vs FEMY Comparison

Compare RYM & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RYM

RYTHM Inc.

N/A

Current Price

$21.00

Market Cap

39.1M

ML Signal

N/A

Logo Femasys Inc.

FEMY

Femasys Inc.

HOLD

Current Price

$0.62

Market Cap

34.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYM
FEMY
Founded
2016
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.1M
34.3M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
RYM
FEMY
Price
$21.00
$0.62
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.83
AVG Volume (30 Days)
241.2K
1.4M
Earning Date
11-07-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$16,303,000.00
$2,061,502.00
Revenue This Year
N/A
$64.02
Revenue Next Year
N/A
$147.19
P/E Ratio
N/A
N/A
Revenue Growth
1338.92
63.53
52 Week Low
$13.22
$0.31
52 Week High
$53.65
$1.80

Technical Indicators

Market Signals
Indicator
RYM
FEMY
Relative Strength Index (RSI) N/A 39.60
Support Level N/A $0.58
Resistance Level N/A $0.66
Average True Range (ATR) 0.00 0.07
MACD 0.00 -0.02
Stochastic Oscillator 0.00 23.93

Price Performance

Historical Comparison
RYM
FEMY

About RYM RYTHM Inc.

Rythm Inc is a USA Based company. The Company's portfolio of brands delivers well-being to millions of Americans every year. The company features some of the recognized and trusted names in the cannabis and hemp industries, including RYTHM, incredibles, Dogwalkers, Beboe, Senorita THC Margaritas, &Shine, Doctor Solomon's and Good Green in thousands of physical locations and online channels. With products rooted in quality, safety, and innovation, the Company is shaping cannabis experiences that enhance daily life.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: